Journal of Biomolecular Structure and Dynamics Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening. By Nilkanta Chowdhury, 4 years ago
Journal of Biomolecular Structure and Dynamics An immunoprophylactic evaluation of Ld-ODC derived HLA-A0201 restricted peptides against visceral leishmaniasis. By Raj Kishor Pandey, 4 years ago
Journal of Biomolecular Structure and Dynamics In silico prediction of SARS-CoV-2 main protease and polymerase inhibitors: 3D-Pharmacophore modelling. By Mona Mosayebnia, 4 years ago
Journal of Biomolecular Structure and Dynamics Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. By Elham Mahdevar, 4 years ago
Journal of Biomolecular Structure and Dynamics Metabolomic profiling of three Araucaria species, and their possible potential role against COVID-19. By Seham S. El-Hawary, 4 years ago
Journal of Biomolecular Structure and Dynamics Synthesis, structural, spectral, antioxidant, bioactivity and molecular docking investigations of a novel triazole derivative. By Can Alaşalvar, 4 years ago
Journal of Biomolecular Structure and Dynamics Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. By F. O. Shode, 4 years ago
Journal of Biomolecular Structure and Dynamics Computational identification of potential lead molecules targeting rho receptor of Neisseria gonorrhoeae. By Sundararaj Rajamanikandan, 4 years ago
Journal of Biomolecular Structure and Dynamics Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy. By Md. Muzahid Ahmed Ezaj, 4 years ago
Journal of Biomolecular Structure and Dynamics In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase. By Anshuman Chandra, 4 years ago